Acro Biomedical (ACBM) Operating Expenses (2015 - 2025)

Acro Biomedical's Operating Expenses history runs 11 years deep, the most recent figure standing at $16377.0 for Q4 2025.

• In Q4 2025, Operating Expenses rose 72.97% year-over-year to $16377.0; the TTM figure through Dec 2025 stood at $154024.0 (up 305.77% YoY), while the FY2025 annual figure was $154024.0, up 305.77% from the prior year.
• Operating Expenses was $16377.0 for Q4 2025 at Acro Biomedical, down from $115099.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $4.0 million in Q3 2022 to a low of $8934.0 in Q1 2025.
• Historically, Operating Expenses has averaged $1.6 million across 5 years, with a median of $494209.5 in 2021.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses soared 4530.64% in 2022, then sank 99.74% in 2024.
• A 5-year view of Operating Expenses shows it stood at $4.0 million in 2021, then retreated by 0.12% to $4.0 million in 2022, then sank by 99.56% to $17401.0 in 2023, then tumbled by 45.59% to $9468.0 in 2024, then jumped by 72.97% to $16377.0 in 2025.
• The last three Operating Expenses figures came in at $16377.0 (Q4 2025), $115099.0 (Q3 2025), and $13614.0 (Q2 2025), per Business Quant data.